As the world continued to battle with efforts aimed at finding cure to
HIV/AIDS, the US Food and Drug Administration (FDA) has announced another
breakthrough in the treatment of the disease with the discovery of an oral
botanical drug, Crofelemer. The new drug is the second botanical, and an
orally administered drug to be approved by FDA since 2006. The latest
breakthrough owes its success to a pioneering research carried out in the
United States by a team of scientists including Nigeria’s Professor Maurice
Iwu, an acclaimed pharmacologist and tropical medicine expert.
The first botanical drug to be approved in the United States was a topical
green tea extract, Veregen, in 2006. Both botanical drugs meet all US
pharmaceutical requirements and can be dispensed only by prescription. However,
‘’Crofelemer is the first drug to be approved in the United States to treat HIV
-associated diarrhea. It is derived from the latex of the South American sangre
de drago tree (dragon’s blood, Croton lechleri). A red, blood-resembling latex
leaks from the tree when its bark is cut, and it is this substance that
contains the novel polymolecular structure crofelemer, originally developed and
standardized by Shaman Pharmaceuticals. Fulyzag is the second botanical drug
approved by the agency. The drug’s approval marks an important event in the
decades-long history of crofelemer.’’
The latest ‘’Healthnews,’’ in a report entitled, ‘’Nigeria’s Maurice
Iwu, others record breakthrough in HIV/AIDS treatment: Amazon tree-derived
medicine cleared for usage in HIV patients with diarrhea,’’ stated, ‘’On New
Year’s Eve of 2012, the US Food and Drug Administration announced its
approval of crofelemer, marking the second time a botanical, and the first time
an orally administered botanical, has received drug approval from the
Administration. The first botanical drug to be approved in the United States
was a topical green tea extract, Veregen in 2006. Both botanical drugs meet all
US pharmaceutical requirements and can be dispensed only by prescription.
’’The latest breakthrough owes its success to a pioneering research
carried out in the United States by a team of scientists which included
Nigeria’s Professor Maurice Iwu, an acclaimed pharmacologist and tropical
medicine expert.
Source: Vanguard Nigeria
No comments:
Post a Comment